Cargando…

Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose

It is not determined whether serum visfatin levels are related to the presence and severity of coronary artery disease (CAD) in non-diabetic subjects. In this study, a total of 65 consecutive non-diabetic participants who underwent coronary angiography were enrolled. Serum visfatin and fasting gluco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fei, Ning, Xiang, Zhao, Tong, Lu, Qinghua, Chen, Huiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449683/ https://www.ncbi.nlm.nih.gov/pubmed/36128447 http://dx.doi.org/10.1515/med-2022-0540

Ejemplares similares

Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016)

Association of Impaired Fasting Blood Glucose With Triple Coronary Artery Stenosis and Myocardial Infarction Among Patients With Coronary Artery Stenosis
por: Chen, Chang, et al.
Publicado: (2022)

Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
por: Tönjes, Anke, et al.
Publicado: (2010)

Impaired fasting glucose is associated with increased severity of subclinical coronary artery disease compared to patients with diabetes and normal fasting glucose: evaluation by coronary computed tomographic angiography
por: Gurudevan, Swaminatha, et al.
Publicado: (2016)

Serum visfatin level is associated with complexity of coronary artery disease in patients with stable angina pectoris
por: Duman, Hakan, et al.
Publicado: (2019)

Visfatin, glucose metabolism and vascular disease: a review of evidence
por: Saddi-Rosa, Pedro, et al.
Publicado: (2010)

Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents
por: Taşkesen, Derya, et al.
Publicado: (2012)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
por: Han, Eugene, et al.
Publicado: (2020)

Subjects with Impaired Fasting Glucose: Evolution in a Period of 6 Years
por: Leiva, E., et al.
Publicado: (2014)

Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose
por: Goossens, Gijs H., et al.
Publicado: (2016)

Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects
por: Saddi-Rosa, Pedro, et al.
Publicado: (2013)

Study of serum visfatin and blood glucose and lipid metabolism, nafld in simple obese children
por: Li, Rui-zhen, et al.
Publicado: (2015)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2012)

Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus
por: Liang, Zhaoxia, et al.
Publicado: (2015)

Increased Arterial Stiffness in Prediabetic Subjects Recognized by Hemoglobin A1c with Postprandial Glucose but Not Fasting Glucose Levels
por: Li, Chung-Hao, et al.
Publicado: (2019)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
por: Zhang, Fang, et al.
Publicado: (2012)

Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose
por: Tasci, Ilker, et al.
Publicado: (2006)

The Role of Visfatin in Diabetic Nephropathy
por: Kang, Young Sun, et al.
Publicado: (2011)

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose
por: Zhang, Jing, et al.
Publicado: (2017)

Periodontitis is associated with the increased levels of visfatin: a meta-analysis
por: Zhu, Junfei, et al.
Publicado: (2023)

Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction
por: Wan, Qiang, et al.
Publicado: (2018)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
por: Chiang, Yi-Fen, et al.
Publicado: (2023)

Impairment of extra-high frequency auditory thresholds in subjects with elevated levels of fasting blood glucose
por: Das, Anindya, et al.
Publicado: (2018)

Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
por: Lee, Jin-Hee, et al.
Publicado: (2021)

Hypertension and cystatin C account for sex differences in serum homocysteine levels in acute coronary syndrome subjects with normal serum creatinine
por: Shang, Kun, et al.
Publicado: (2023)

Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010)

Visfatin Induces Sickness Responses in the Brain
por: Park, Byong Seo, et al.
Publicado: (2011)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013)

Adipokines Vaspin and Visfatin in Obese Children
por: Salama, Hassan M., et al.
Publicado: (2015)

Visfatin level in patients with colorectal adenoma
por: Fazeli, Mohammad Sadegh, et al.
Publicado: (2016)

The relation of visfatin with nausea and vomiting in the pregnancy
por: Jahani, Farnaz, et al.
Publicado: (2020)

Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast
por: Legakis, Ioannis, et al.
Publicado: (2016)

Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells
por: Chiu, Chiung‐Zuan, et al.
Publicado: (2020)

Association of plasma visfatin with epicardial fat thickness and severity of coronary artery diseases in patients with acute myocardial infarction and stable angina pectoris
por: Avesta, Leli, et al.
Publicado: (2022)

Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
por: Suzuki, Keishi, et al.
Publicado: (2016)

Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
por: Kanat, Mustafa, et al.
Publicado: (2012)

Fasting Glucose, Obesity, and Coronary Artery Calcification in Community-Based People Without Diabetes
por: Rutter, Martin K., et al.
Publicado: (2012)

Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018)

Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial
por: Jeong, Sarang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3i7vl1vr4ug0jas7m989ap02d